US Stock MarketDetailed Quotes

PTCT PTC Therapeutics

Watchlist

28.570
+3.080+12.08%

Close Apr 26 16:00 ET

28.650
+0.080+0.28%

Post 18:44 ET

2.19BMarket Cap-3715P/E (TTM)

PTC Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

34.20%937.82M

83.41%307.06M

-9.46%196.58M

29.17%213.81M

48.17%220.38M

29.75%698.8M

1.32%167.41M

56.50%217.13M

41.87%165.53M

26.11%148.74M

Operating revenue

34.20%937.82M

83.41%307.06M

-9.46%196.58M

29.17%213.81M

48.17%220.38M

29.75%698.8M

1.32%167.41M

56.50%217.13M

41.87%165.53M

26.11%148.74M

Cost of revenue

46.57%65.49M

167.31%29.12M

-32.25%9.49M

32.08%12.73M

39.56%14.14M

38.20%44.68M

16.79%10.89M

114.27%14.01M

31.00%9.64M

11.32%10.14M

Gross profit

33.36%872.34M

77.57%277.94M

-7.89%187.08M

28.99%201.08M

48.80%206.24M

29.21%654.12M

0.40%156.52M

53.64%203.12M

42.60%155.89M

27.35%138.6M

Operating expense

11.67%1.22B

-13.35%274.82M

9.81%303.75M

22.12%321.72M

35.74%321.45M

24.15%1.09B

25.50%317.18M

28.96%276.6M

27.20%263.45M

14.47%236.82M

Selling and administrative expenses

2.01%332.54M

-17.72%76.29M

0.96%80.89M

10.71%88.45M

18.62%86.91M

14.08%326M

7.13%92.72M

15.69%80.12M

15.99%79.89M

19.93%73.27M

-General and administrative expense

----

0.96%80.89M

----

--80.12M

----

Research and development costs

2.31%666.56M

-35.69%121.35M

-0.76%164.21M

18.19%185.87M

39.30%195.12M

20.49%651.5M

25.93%188.69M

26.46%165.46M

25.33%157.26M

4.14%140.08M

Depreciation amortization depletion

91.01%222.64M

115.79%77.17M

89.05%58.65M

80.26%47.4M

67.92%39.42M

112.88%116.55M

118.87%35.76M

115.69%31.02M

106.21%26.29M

108.13%23.47M

-Depreciation and amortization

91.01%222.64M

115.79%77.17M

89.05%58.65M

80.26%47.4M

67.92%39.42M

112.88%116.55M

118.87%35.76M

115.69%31.02M

106.21%26.29M

108.13%23.47M

Operating profit

20.58%-349.4M

101.94%3.12M

-58.75%-116.66M

-12.16%-120.64M

-17.30%-115.22M

-17.33%-439.93M

-65.92%-160.66M

10.68%-73.49M

-9.99%-107.56M

-0.18%-98.22M

Net non-operating interest income expense

-42.16%-129.18M

-80.71%-44.28M

-34.87%-28.16M

-33.85%-29.42M

-16.23%-27.33M

-5.64%-90.87M

-8.88%-24.5M

4.23%-20.88M

2.58%-21.98M

-22.73%-23.51M

Non-operating interest expense

42.16%129.18M

80.71%44.28M

34.87%28.16M

33.85%29.42M

16.23%27.33M

5.64%90.87M

8.88%24.5M

-4.23%20.88M

-2.58%21.98M

22.73%23.51M

Other net income (expense)

-283.71%-217.53M

-2,455.03%-115.9M

33.72%-21.77M

-356.34%-87.42M

4,974.84%7.56M

1.19%-56.69M

76.47%-4.54M

-11.02%-32.84M

-875.59%-19.16M

98.59%-155K

Special income (charges)

-2,941.93%-227.66M

-239.83%-134.86M

-128.30%-1.5M

-684.87%-88.9M

-120.51%-2.4M

-1,596.80%-7.48M

-427.97%-39.68M

149.07%5.3M

2,271.43%15.2M

11,800.00%11.7M

-Less：Restructuring and merger&acquisition

-393.05%-127.7M

-142.86%-2.7M

128.30%1.5M

-748.03%-128.9M

120.51%2.4M

-5,080.00%-25.9M

152.07%6.3M

-149.07%-5.3M

-2,271.43%-15.2M

-11,800.00%-11.7M

-Less:Impairment of capital assets

552.41%217.8M

--0

--217.8M

----

--33.38M

--0

----

-Less:Other special charges

--137.56M

----

Other non- operating income (expenses)

120.59%10.13M

-46.05%18.96M

46.87%-20.27M

104.30%1.48M

183.98%9.96M

14.98%-49.21M

212.02%35.15M

-103.07%-38.14M

-1,183.82%-34.36M

-8.92%-11.86M

Income before tax

-18.49%-696.11M

17.21%-157.05M

-30.96%-166.59M

-59.71%-237.48M

-10.75%-134.99M

-13.34%-587.49M

-36.86%-189.69M

4.83%-127.21M

-26.14%-148.7M

4.91%-121.89M

Income tax

-144.14%-69.51M

93.30%-1.26M

-87.89%-33.62M

-1,237.85%-38.6M

-17.91%3.97M

-611.96%-28.47M

-503.78%-18.8M

-49,602.78%-17.89M

595.08%3.39M

972.06%4.84M

Net income

-12.09%-626.6M

8.83%-155.79M

-21.64%-132.97M

-30.77%-198.88M

-9.65%-138.96M

-6.70%-559.02M

-19.28%-170.89M

18.19%-109.32M

-28.48%-152.09M

1.49%-126.73M

Net income continuous Operations

-12.09%-626.6M

8.83%-155.79M

-21.64%-132.97M

-30.77%-198.88M

-9.65%-138.96M

-6.70%-559.02M

-19.28%-170.89M

18.19%-109.32M

-28.48%-152.09M

1.49%-126.73M

Minority interest income

Net income attributable to the parent company

-12.09%-626.6M

8.83%-155.79M

-21.64%-132.97M

-30.77%-198.88M

-9.65%-138.96M

-6.70%-559.02M

-19.28%-170.89M

18.19%-109.32M

-28.48%-152.09M

1.49%-126.73M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-12.09%-626.6M

8.83%-155.79M

-21.64%-132.97M

-30.77%-198.88M

-9.65%-138.96M

-6.70%-559.02M

-19.28%-170.89M

18.19%-109.32M

-28.48%-152.09M

1.49%-126.73M

Basic earnings per share

-7.45%-8.37

12.34%-2.06

-15.03%-1.76

-24.88%-2.66

-5.62%-1.88

-4.85%-7.79

-15.76%-2.35

19.05%-1.53

-26.79%-2.13

2.73%-1.78

Diluted earnings per share

-7.45%-8.37

12.34%-2.06

-15.03%-1.76

-24.88%-2.66

-5.62%-1.88

-4.85%-7.79

-15.76%-2.35

19.05%-1.53

-26.79%-2.13

2.73%-1.78

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	34.20%937.82M	83.41%307.06M	-9.46%196.58M	29.17%213.81M	48.17%220.38M	29.75%698.8M	1.32%167.41M	56.50%217.13M	41.87%165.53M	26.11%148.74M
Operating revenue	34.20%937.82M	83.41%307.06M	-9.46%196.58M	29.17%213.81M	48.17%220.38M	29.75%698.8M	1.32%167.41M	56.50%217.13M	41.87%165.53M	26.11%148.74M
Cost of revenue	46.57%65.49M	167.31%29.12M	-32.25%9.49M	32.08%12.73M	39.56%14.14M	38.20%44.68M	16.79%10.89M	114.27%14.01M	31.00%9.64M	11.32%10.14M
Gross profit	33.36%872.34M	77.57%277.94M	-7.89%187.08M	28.99%201.08M	48.80%206.24M	29.21%654.12M	0.40%156.52M	53.64%203.12M	42.60%155.89M	27.35%138.6M
Operating expense	11.67%1.22B	-13.35%274.82M	9.81%303.75M	22.12%321.72M	35.74%321.45M	24.15%1.09B	25.50%317.18M	28.96%276.6M	27.20%263.45M	14.47%236.82M
Selling and administrative expenses	2.01%332.54M	-17.72%76.29M	0.96%80.89M	10.71%88.45M	18.62%86.91M	14.08%326M	7.13%92.72M	15.69%80.12M	15.99%79.89M	19.93%73.27M
-General and administrative expense	----	----	0.96%80.89M	----	----	----	----	--80.12M	----	----
Research and development costs	2.31%666.56M	-35.69%121.35M	-0.76%164.21M	18.19%185.87M	39.30%195.12M	20.49%651.5M	25.93%188.69M	26.46%165.46M	25.33%157.26M	4.14%140.08M
Depreciation amortization depletion	91.01%222.64M	115.79%77.17M	89.05%58.65M	80.26%47.4M	67.92%39.42M	112.88%116.55M	118.87%35.76M	115.69%31.02M	106.21%26.29M	108.13%23.47M
-Depreciation and amortization	91.01%222.64M	115.79%77.17M	89.05%58.65M	80.26%47.4M	67.92%39.42M	112.88%116.55M	118.87%35.76M	115.69%31.02M	106.21%26.29M	108.13%23.47M
Operating profit	20.58%-349.4M	101.94%3.12M	-58.75%-116.66M	-12.16%-120.64M	-17.30%-115.22M	-17.33%-439.93M	-65.92%-160.66M	10.68%-73.49M	-9.99%-107.56M	-0.18%-98.22M
Net non-operating interest income expense	-42.16%-129.18M	-80.71%-44.28M	-34.87%-28.16M	-33.85%-29.42M	-16.23%-27.33M	-5.64%-90.87M	-8.88%-24.5M	4.23%-20.88M	2.58%-21.98M	-22.73%-23.51M
Non-operating interest expense	42.16%129.18M	80.71%44.28M	34.87%28.16M	33.85%29.42M	16.23%27.33M	5.64%90.87M	8.88%24.5M	-4.23%20.88M	-2.58%21.98M	22.73%23.51M
Other net income (expense)	-283.71%-217.53M	-2,455.03%-115.9M	33.72%-21.77M	-356.34%-87.42M	4,974.84%7.56M	1.19%-56.69M	76.47%-4.54M	-11.02%-32.84M	-875.59%-19.16M	98.59%-155K
Special income (charges)	-2,941.93%-227.66M	-239.83%-134.86M	-128.30%-1.5M	-684.87%-88.9M	-120.51%-2.4M	-1,596.80%-7.48M	-427.97%-39.68M	149.07%5.3M	2,271.43%15.2M	11,800.00%11.7M
-Less：Restructuring and merger&acquisition	-393.05%-127.7M	-142.86%-2.7M	128.30%1.5M	-748.03%-128.9M	120.51%2.4M	-5,080.00%-25.9M	152.07%6.3M	-149.07%-5.3M	-2,271.43%-15.2M	-11,800.00%-11.7M
-Less:Impairment of capital assets	552.41%217.8M	--0	--0	--217.8M	----	--33.38M	--33.38M	--0	--0	----
-Less:Other special charges	--137.56M	----	----	----	----	----	----	----	----	----
Other non- operating income (expenses)	120.59%10.13M	-46.05%18.96M	46.87%-20.27M	104.30%1.48M	183.98%9.96M	14.98%-49.21M	212.02%35.15M	-103.07%-38.14M	-1,183.82%-34.36M	-8.92%-11.86M
Income before tax	-18.49%-696.11M	17.21%-157.05M	-30.96%-166.59M	-59.71%-237.48M	-10.75%-134.99M	-13.34%-587.49M	-36.86%-189.69M	4.83%-127.21M	-26.14%-148.7M	4.91%-121.89M
Income tax	-144.14%-69.51M	93.30%-1.26M	-87.89%-33.62M	-1,237.85%-38.6M	-17.91%3.97M	-611.96%-28.47M	-503.78%-18.8M	-49,602.78%-17.89M	595.08%3.39M	972.06%4.84M
Net income	-12.09%-626.6M	8.83%-155.79M	-21.64%-132.97M	-30.77%-198.88M	-9.65%-138.96M	-6.70%-559.02M	-19.28%-170.89M	18.19%-109.32M	-28.48%-152.09M	1.49%-126.73M
Net income continuous Operations	-12.09%-626.6M	8.83%-155.79M	-21.64%-132.97M	-30.77%-198.88M	-9.65%-138.96M	-6.70%-559.02M	-19.28%-170.89M	18.19%-109.32M	-28.48%-152.09M	1.49%-126.73M
Minority interest income
Net income attributable to the parent company	-12.09%-626.6M	8.83%-155.79M	-21.64%-132.97M	-30.77%-198.88M	-9.65%-138.96M	-6.70%-559.02M	-19.28%-170.89M	18.19%-109.32M	-28.48%-152.09M	1.49%-126.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-12.09%-626.6M	8.83%-155.79M	-21.64%-132.97M	-30.77%-198.88M	-9.65%-138.96M	-6.70%-559.02M	-19.28%-170.89M	18.19%-109.32M	-28.48%-152.09M	1.49%-126.73M
Basic earnings per share	-7.45%-8.37	12.34%-2.06	-15.03%-1.76	-24.88%-2.66	-5.62%-1.88	-4.85%-7.79	-15.76%-2.35	19.05%-1.53	-26.79%-2.13	2.73%-1.78
Diluted earnings per share	-7.45%-8.37	12.34%-2.06	-15.03%-1.76	-24.88%-2.66	-5.62%-1.88	-4.85%-7.79	-15.76%-2.35	19.05%-1.53	-26.79%-2.13	2.73%-1.78
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall